Metabolism · Nov 9, 2026

Aflatoxin B1-induced metabolic remodeling promotes liver injury through an H3K18la–ACSL4–ferroptosis axis attenuated by Urolithin A

By Zhou R, Bian Y, Bu Y et al.

Background Aflatoxin B1 (AFB1) is a pervasive food-and feed-borne mycotoxin that disrupts hepatic homeostasis, but how toxin-induced metabolic stress is converted into redox imbalance, lipid peroxidation and sustained liver injury remains incompletely understood. Methods We investigated AFB1-induced hepatotoxicity using a mouse exposure model, AML12 hepatocytes and THLE-2 human liver epithelial cells, combined with cross-species transcriptomic analysis, metabolic inhibition, gene silencing, ChIP-qPCR, ferroptosis inhibition and Urolithin A intervention. Results AFB1 exposure induced hepatic dysfunction, inflammatory activation, mitochondrial abnormalities, lactate accumulation, Fe²⁺/ROS imbalance and lipid peroxidation. Cross-species transcriptomic analysis revealed recurrent enrichment of glycolytic, oxidative-stress and ferroptosis-associated programs. Mechanistically, AFB1 enhanced glycolytic remodeling and lactate production, accompanied by increased histone H3 lysine 18 lactylation (H3K18la). Inhibition of Ldha or glycolysis reduced lactate accumulation, H3K18la abundance and hepatocyte injury. Integrated ferroptosis-gene screening and ChIP-qPCR identified Acsl4 as an AFB1-responsive effector associated with H3K18la enrichment at promoter-associated chromatin. Acsl4 silencing or Fer-1 treatment attenuated ACSL4 induction, GPX4 loss, lipid peroxidation and inflammatory injury. THLE-2 cells further recapitulated key molecular features of this H3K18la–ACSL4–ferroptosis program. Urolithin A protected against AFB1 hepatotoxicity in association with attenuation of this pathway. Conclusions This study defines a metabolic-epigenetic mechanism linking AFB1-induced lactate accumulation to ACSL4-associated ferroptotic liver injury and highlights Urolithin A as a potential intervention against food- and feed-borne mycotoxin-induced hepatotoxicity.

doi.org/10.1016/j.metabol.2026.156813PubMed 43003254Interventions

AgingResearch.News